| Year |
Citation |
Score |
| 2024 |
Farrokhi AM, Moshrefi F, Eskandari K, Azizbeigi R, Haghparast A. Hippocampal D1-like dopamine receptor as a novel target for the effect of cannabidiol on extinction and reinstatement of methamphetamine-induced CPP. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 133: 111025. PMID 38729234 DOI: 10.1016/j.pnpbp.2024.111025 |
0.598 |
|
| 2024 |
Moshrefi F, Farrokhi AM, Fattahi M, Azizbeigi R, Haghparast A. The role of orexin receptors within the CA1 area in the acquisition and expression of methamphetamine place preference. Journal of Psychiatric Research. 172: 291-299. PMID 38428165 DOI: 10.1016/j.jpsychires.2024.02.051 |
0.532 |
|
| 2024 |
Nazari-Serenjeh F, Sadeghi M, Azizbeigi R, Semizeh H, Mazaheri S, Haghparast A, Haghparast A. Blocking the dopaminergic receptors within the hippocampal dentate gyrus reduced analgesic responses induced by restraint stress in the formalin test. Behavioural Brain Research. 114914. PMID 38368953 DOI: 10.1016/j.bbr.2024.114914 |
0.552 |
|
| 2023 |
Mohammadi M, Eskandari K, Azizbeigi R, Haghparast A. The inhibitory effect of cannabidiol on the rewarding properties of methamphetamine in part mediates by interacting with the hippocampal D1-like dopamine receptors. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 126: 110778. PMID 37100273 DOI: 10.1016/j.pnpbp.2023.110778 |
0.61 |
|
| 2022 |
Nazari-Serenjeh F, Azizbeigi R, Rashvand M, Mesgar S, Amirteymori H, Haghparast A. Distinct roles for orexin-1 and orexin-2 receptors in the dentate gyrus of the hippocampus in the methamphetamine-seeking behavior in the rats. Life Sciences. 312: 121262. PMID 36470538 DOI: 10.1016/j.lfs.2022.121262 |
0.603 |
|
| 2022 |
Chizari A, Hassanpour R, Karimi-Haghighi S, Azizbeigi R, Mesgar S, Mousavi Z, Haghparast A. Compensatory Role of Insulin in the Extinction but Not Reinstatement of Morphine-Induced Conditioned Place Preference in the Streptozotocin-Induced Diabetic Rats. Neurochemical Research. PMID 35188597 DOI: 10.1007/s11064-022-03550-y |
0.525 |
|
| 2020 |
Nazari-Serenjeh F, Zarrabian S, Azizbeigi R, Haghparast A. Effects of dopamine D1- and D2-like receptors in the CA1 region of the hippocampus on expression and extinction of morphine-induced conditioned place preference in rats. Behavioural Brain Research. 397: 112924. PMID 32976861 DOI: 10.1016/j.bbr.2020.112924 |
0.631 |
|
| 2019 |
Azizbeigi R, Farzinpour Z, Haghparast A. Role of Orexin-1 Receptor Within the Ventral Tegmental Area in Mediating Stress- and Morphine Priming-induced Reinstatement of Conditioned Place Preference in Rats. Basic and Clinical Neuroscience. 10: 373-382. PMID 32231774 DOI: 10.32598/Bcn.9.10.130 |
0.578 |
|
| 2018 |
Azizbeigi R, Haghparast A. Involvement of orexin-2 receptor in the ventral tegmental area in stress- and drug priming-induced reinstatement of conditioned place preference in rats. Neuroscience Letters. PMID 30579995 DOI: 10.1016/J.Neulet.2018.12.029 |
0.654 |
|
| 2018 |
Farzinpour Z, Taslimi Z, Azizbeigi R, Karimi-Haghighi S, Haghparast A. Involvement of orexinergic receptors in the nucleus accumbens, in the effect of forced swim stress on the reinstatement of morphine seeking behaviors. Behavioural Brain Research. 356: 279-287. PMID 30195020 DOI: 10.1016/J.Bbr.2018.08.021 |
0.643 |
|
| 2014 |
Ahmadi S, Golbaghi H, Azizbeigi R, Esmailzadeh N. N-methyl-D-aspartate receptors involved in morphine-induced hyperalgesia in sensitized mice. European Journal of Pharmacology. 737: 85-90. PMID 24842190 DOI: 10.1016/J.Ejphar.2014.04.048 |
0.511 |
|
| 2013 |
Azizbeigi R, Zarrindast MR, Ahmadi S. Interaction between gamma-aminobutyric acid type A (GABAA) receptor agents and scopolamine in the nucleus accumbens on impairment of inhibitory avoidance memory performance in rat Behavioural Brain Research. 241: 191-197. PMID 23261876 DOI: 10.1016/J.Bbr.2012.12.022 |
0.397 |
|
| 2011 |
Azizbeigi R, Ahmadi S, Babapour V, Rezayof A, Zarrindast MR. Nicotine restores morphine-induced memory deficit through the D1 and D2 dopamine receptor mechanisms in the nucleus accumbens. Journal of Psychopharmacology (Oxford, England). 25: 1126-33. PMID 21616978 DOI: 10.1177/0269881111405354 |
0.519 |
|
| Show low-probability matches. |